Indicate which medical condition(s) the student has, including family medical history, for which MMR vaccine is contraindicated: ☐ Severe allergic reaction after a previous dose or to a vaccine component ☐ Pregnancy ☐ Known severe immunodeficiency (e.g., from hematologic and solid tumors, receipt of chemotherapy, congenital immunodeficiency, long-term immunosuppressive therapy, or patients with HIV infection who受到严重免疫功能低下)☐一级亲戚的先天/遗传免疫缺陷的家族史
Acid-Fast Bacillus Acquired immunodeficiency syndrome Antiretroviral treatment Bronchoalveolar Lavage Bacillus Calmette-Guérin Bedaquiline, Pretomanid and Linezolid Bedaquiline, Pretomanid, Linezolid and Moxifloxacin Computer-Aided Detection United States Centers for Disease Control and Prevention Central Nervous System Cerebrospinal Fluid Chest X-Ray Directly Observed Treatment Drug Susceptible Drug susceptibility testing Extrapulmonary Fixed-dose combination Fine Needle Aspiration Fine Needle Aspiration Cytology Guideline Development Group Global TB Programme Germicidal Ultraviolet High-Efficiency Particulate Air Human immunodeficiency virus Isoniazid and Rifampicin Isoniazid, and Rifampicin, with Ethambutol Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol Internally Displaced人们感染的预防和控制异念珠菌
AE adverse event AESI adverse event of special interest AIDS acquired immunodeficiency syndrome ARDS acute respiratory distress syndrome CBRN chemical, biological, radiological, or nuclear CDC Centers for Disease Control and Prevention EUA Emergency Use Authorization FDA Food and Drug Administration hACE2 human angiotensin converting enzyme 2 HHS Health and Human Services HIV human immunodeficiency virus IM intramuscular LNP脂质纳米粒子中东呼吸综合征mRNA Messenger RNA NAAT NAAT核酸扩增基于测试RT-PCR逆转录 - 转录 - 聚合酶链链反应SAE严重不良事件SARS-COV-SARS-COV-2严重急性急性呼吸道呼吸道综合征2 VE疫苗效应VRBPAC效应VRBPAC效果
§ Human immunodeficiency virus or acquired immune deficiency syndrome § Cancer § Diabetes § Neurodegenerative diseases § Auto-immune and other immune dysfunctions § Viral diseases o Medicines derived from biotechnology processes, such as genetic engineering o Gene, cell, or tissue-engineered ‘advanced-therapy medicinal products' (ATMPs) o Orphan药品•…强制性范围只能通过集中程序在欧盟授权
ART Antiretroviral Therapy ARV Antiretroviral EPAR European Public Assessment Report HIV -1 Human Immunodeficiency Virus Type 1 HSE Health Service Executive MAP Managed Access Protocol MDR Multidrug Resistant Mg Milligrams MMP Medicines Management Programme PCRS Primary Care Reimbursement Service RNA Ribonucleic acid SmPC Summary of product characteristics
AFCOR Africa Task Force for Novel Coronavirus AfCDC African Centre for Disease Control AfCFTA African Continental Free Trade Area AIDS Acquired Immunodeficiency Syndrome ATM Automated Teller Machine AU African Union AUC African Union Commission BOM Bank of Mauritius CBR Central Bank Rate CCRT Catastrophe Containment and Relief Trust CFTA Continental Free Trade Area CIT Corporate Income Tax CMI COMESA Monetary Institute东部和南部非洲的Comea Common Market Comstat Comea Casea统计Portal Covid-19 2019年冠状病毒疾病。EAC East African Community ECA Economic Commission for Africa ELA Emergency Liquidity Assistance EU European Union FDI Foreign Direct Investment FMCPI Free Market Price Index FTA Free Trade Area FX Foreign Exchange GATS General Agreement on Trade in Services GDP Gross Domestic Product HCPI COMESA Harmonised Consumer Price Index HIV Human Immunodeficiency Virus IATA International Air Transport Association
D80 Immunodeficiency with predominantly antibody defects D80.0* Hereditary hypogammaglobulinemia Autosomal recessive agammaglobulinemia (Swiss type) X-linked agammaglobulinemia [Bruton] (with growth hormone deficiency) D80.1 Nonfamilial hypogammaglobulinemia Agammaglobulinemia含有免疫球蛋白的B-淋巴细胞常见可变的agammagaglobulinemia [cvagamma] hardogammagagamaglobulinemia nos d80.2*免疫球蛋白A [IgA] D80.3*的选择性缺陷d80.3*选择性缺陷型免疫缺陷效率。免疫球蛋白M [IgM] D80.5*免疫缺陷率提高免疫球蛋白M [IgM] D80.6*抗体缺乏效率近期免疫球蛋白或与临时抗肿瘤的临时抗肿瘤d880.8其他免疫原性D880.8缺陷Kappa轻链缺乏D80.9免疫缺陷,主要是抗体缺陷,未指定的
AVRR Assisted Voluntary Return and Reintegration BLA Bilateral Labour Agreement BLMAs Bilateral Labour Migration Agreements BMIS Border Management Information System CBOs Community-Based Organisations CMP Common Market Protocol COMESA Common Market for Eastern and Southern Africa COPTIP Coordination Office for Prevention of Trafficking in Persons COVID-19 Corona Virus Disease of 2019 CRRF Comprehensive Refugee Response Framework DCIC Directorate of Citizenship and Immigration Control EAC East African Community EHA East and Horn of Africa EVD Ebola Virus Disease GBV Gender-Based Violence GCM Global Compact for Migration GDP Gross Domestic Product GoU Government of Uganda GRF Global Results Framework HBMM Health, Border and Mobility Management HIV/AIDs Human Immunodeficiency Virus/ Acquired Immunodeficiency Syndrome HMIS Health Management Information System IBG Immigration and Border治理IGAD政府间发展局ILO国际劳工组织INGO国际非政府组织IOM国际移民组织IPC IPC综合粮食安全阶段分类ITA移民培训学院Kyc Kyc keyc sew-customer mcof mcof移民危机运营框架
•获得的免疫缺陷综合征•人类免疫缺陷病毒(HIV)的最先进的感染阶段•HIV是一种杀死或损害人体免疫系统细胞的病毒y•HIV•HIV通过 - 与受感染的人 - 与受感染的人相处或受感染的人的症状•与妇女的血液相处•与妇女的血液相处•与妇女的血液接触,•与他们的血液接触,并且<
Immunodeficiences Adenosine deaminase deficiency Ataxia telangiectasia Chronic granulomatous disease Complete IFN- γ Receptor 2 Deficiency DiGeorge syndrome IKK gamma deficiency Immune dysregulation polyendocrineopathy Leukocyte adhesion deficiency LRBA deficiency Myelokathexis X-linked immunodeficiency Omenn's syndrome Reticular dysplasia严重的联合免疫缺陷(SCID)胸腺发育不全Wiskott-Aldrich综合征X连接的Agammagloblobloblinemia X连接的淋巴增生性疾病X连锁粘脂性粘脂性粘液脂质变性,II型